TokenPost topic

XmAb819

1 TokenPost story is tagged XmAb819. The newest appear first.

Latest XmAb819 stories

• Xencor Shares Climb 23.94% on XmAb819 Kidney Cancer Results

  A Phase 1 study showed a 45.5% response rate in advanced kidney cancer. Xencor plans accelerated discussions with the Food and Drug Administration.

  Oct 26, 2026, 5:46 AM EDT · Investing